AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 56 of 93

57 Table 28. Valvular Pulmonary Stenosis: Routine Follow-Up and Testing Intervals Type of Follow-Up or Testing Physiological Stage A* (mo) Physiological Stage B* (mo) Physiological Stage C* (mo) Physiological Stage D* (mo) Outpatient ACHD cardiologist 36–60 24 6–12 3–6 Electrocardiogram 36–60 24 12 12 Transthoracic echocardiogram 36–60 24 12 12 Modified with permission from Stout et al. Copyright © 2018 American Heart Association, Inc. and American College of Cardiolog y Foundation. * See Section 2.2 for details on the ACHD anatomic and physiological classification system. ACHD indicates adult congenital heart disease. 4.3.2.1. Isolated Pulmonary Regurgitation After Repair of Pulmonary Stenosis COR LOE Recommendations Diagnostic 1 B-NR 1. In adults with moderate or greater pulmonary regurgitation resulting from treated isolated valvular pulmonary stenosis, CMR imaging is recommended to establish anatomy, quantify the degree of regurgitation, and measure RV volumes and systolic function. erapeutic 1 B-NR 2. In patients with symptomatic moderate or greater pulmonary regurgitation resulting from treated isolated valvular pulmonary stenosis, pulmonary valve replacement is recommended to improve symptoms. 2a C-LD 3. In asymptomatic patients with moderate or greater pulmonary regurgitation resulting from treatment of isolated pulmonary stenosis with RV systolic dysfunction, pulmonary valve replacement is reasonable to restore valve function and preserve RV systolic function. 2b C-LD 4. In asymptomatic patients who have moderate or greater pulmonary regurgitation resulting from treatment of isolated pulmonary stenosis and at least moderate tricuspid regurgitation and/or progressive RV dilation or progressive decline in exercise capacity,* pulmonary valve replacement may be reasonable to restore valve function, ameliorate RV size, and preserve RV systolic function. * See Figure 5.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease